缺席发作产生背后的分子机制:确定治疗干预的潜在目标
1Department of Anatomy, School of Biomedical Sciences, Brain Health Research Centre, University of Otago, Dunedin 9054, New Zealand.
International journal of molecular sciences
|September 28, 2024
概括
了解童年缺席 (CAE) 的机制是新治疗的关键. 目前的治疗方法对许多人来说是无效的,这凸显了针对发作原因的精准医学的需要.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 的研究研究.
背景情况:
- 儿童缺席 (CAE) 影响了许多儿童,其中很大一部分对当前的抗发作药物 (ASM) 没有反应.
- 现有的CAE的ASM可能会导致不良影响,并可能使一些人的发作恶化.
- 由于CAE的复杂性和多因素性,受到各种遗传背景的影响,使理解其精确的细胞和分子基础变得复杂.
研究的目的:
- 审查目前对驱动CAE缺席发作的分子机制的知识.
- 确定开发新型无副作用精密药物的潜在治疗点.
- 为未来的干预策略巩固前沿研究的见解.
主要方法:
- 关于缺席发作的最新科学文献的综述.
- 分析使用先进技术研究CAE机制的研究.
- 综合与CAE中异常神经元活动相关的发现.
主要成果:
- 缺席发作的确切细胞和分子原因是复杂的,并没有完全阐明.
- 异常的神经元活动与CAE有关,但确切的机制需要进一步研究.
- 尖端技术正在揭示对潜在的致病因素的新见解.
结论:
- 更深入地了解CAE的分子机制对于推进治疗选择至关重要.
- 确定特定的因果因素可以指导开发具有减少副作用的向疗法.
- 本综述为未来的研究提供了基础,旨在为CAE提供有效的个性化干预措施.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181
Antiepileptic Drugs: Glutamate Antagonists
292
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
292
Antiepileptic Drugs: Sodium Channel Blockers
449
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
449
Antiepileptic Drugs: Calcium Channel Blockers
338
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
338


